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Background: Studies provide compelling evidences for particulate matter (PM) associated cardiovascular health
effects. Elderly individuals, particularly those with preexisting conditions like hypertension are regarded to be
vulnerable. Experimental data are warranted to reveal the molecular pathomechanism of PM related cardiovascular
impairments among aged/predisposed individuals. Thus we investigated the cardiovascular effects of ultrafine
carbon particles (UfCP) on aged (12–13 months) spontaneously hypertensive rats (SHRs) and compared the findings
with our pervious study on adult SHRs (6–7 months) to identify age related predisposition events in cardiovascular
compromised elderly individuals.
Methods: Aged SHRs were inhalation exposed to UfCP for 24 h (~180 μg/m3) followed by radio-telemetric
assessment for blood pressure (BP) and heart rate (HR). Bronchoalveolar lavage (BAL) fluid cell differentials,
interleukin 6 (IL-6) and other proinflammatory cytokines; serum C-reactive protein (CRP) and haptoglobin (HPT);
and plasma fibrinogen were measured. Transcript levels of hemeoxygenase 1 (HO-1), endothelin 1 (ET1), endothelin
receptors A, B (ETA, ETB), tissue factor (TF), and plasminogen activator inhibitor-1 (PAI-1) were measured in the lung
and heart to assess oxidative stress, endothelial dysfunction and coagulation cascade.
Result: UfCP exposed aged SHRs exhibited increased BP (4.4%) and HR (6.3%) on 1st recovery day paralleled by a
58% increase of neutrophils and 25% increase of IL-6 in the BAL fluid. Simultaneously higher CRP, HPT and
fibrinogen levels in exposed SHRs indicate systemic inflammation. HO-1, ET1, ET-A, ET-B, TF and PAI-1 were induced
by 1.5-2.0 folds in lungs of aged SHRs on 1st recovery day. However, in UfCP exposed adult SHRs these markers
were up-regulated (2.5-6 fold) on 3rd recovery day in lung without detectable pulmonary/systemic inflammation.
Conclusions: The UfCP induced pulmonary and systemic inflammation in aged SHRs is associated with oxidative
stress, endothelial dysfunction and disturbed coagulatory hemostasis. UfCP exposure increased BP and HR in aged
SHRs rats which was associated with lung inflammation, and increased expression of inflammatory, vasoconstriction
and coagulation markers as well as systemic changes in biomarkers of thrombosis in aged SHRs. Our study provides
further evidence for potential molecular mechanisms explaining the increased risk of particle mediated cardiac
health effects in cardiovascular compromised elderly individuals.
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Air pollution mediated cardiopulmonary effects are one
of the major public health concerns in industrialized
cities throughout the world [1-4]. It is well known that
episodes of air pollution are associated with increased
emergency room visits due to cardiopulmonary impair-
ments as well as increased morbidity and mortality rates.
The majority of the effects occurred among elderly
individuals and those with pre-existing disorder/s like
cardiovascular diseases (CVD), respiratory ailments and
diabetes [5,6]. There is a growing concern about the po-
tential health hazards caused particularly by increased
emissions of combustion derived ultrafine particles
(UFPs) from motor vehicles [7,8]. Motor-vehicle emis-
sions consist of a complex mixture of particulate, che-
mical and gaseous pollutants such as fine particulate
matter (PM2.5; diameter < 2.5 μm), ultrafine particles
(UFPs; diameter < 0.1 μm), metals, volatile organic ma-
terial, black carbon, ozone etc. [7,8]. Several epidemio-
logical studies suggested that the carbonaceous UFPs
emitted from diesel-powered motor vehicles and other
combustion sources induce airway inflammation and re-
duced lung function [9,10]. Nemmar et al. [11] reported
that inhalation of ambient ultrafine carbon particles
(UfCP) and/or nanoparticles not only induce inflamma-
tory responses and oxidative stress but may also have
immune-suppressive effects, impairing macrophage func-
tion and altering epithelial barrier functions. Furthermore,
the initiated inflammatory reaction releases mediators
capable of exacerbating lung disease and increasing
blood coagulability among predisposed individuals [12].
Similarly Schwarze et al. [13] have shown series of evi-
dence suggesting that prolonged airway inflammation
associated with PM exposure may lead to systemic in-
flammation which may increase the susceptibility to
acute cardiovascular effects. UfCP, by virtue of their small
size can easily penetrate into the deep lung (alveolar
compartment) and also impair airway mucocillary clear-
ance [14,15]. UfCP and components of PM can enter into
the blood stream and are translocated to extrapulmonary
organs like heart, liver, brain [16-18]. The large surface
area of UfCP facilitates release of soluble potentially toxic
chemicals thereby causing cell injuries [19-22]. UfCP
constitutes the core of combustion derived particles and
represents relevant surrogates for exhaust particles from
modern diesel engines [23-25]. UfCPs regardless of their
different sources like combustion-derived ultrafine parti-
cles or carbon based engineered nanoparticles, are often
included in commonly applied products such as rubber,
inks, paints and reinforcing agents in tires are of toxico-
logical interest given their small dimensions with proper-
ties not displayed by their macroscopic counterparts
[26,27]. The pulmonary deposition efficiency of inhaled
UFPs, along with chemical constituents easily absorbedon their large surface area, are considered to drive the
emerging health effects linked to cardiopulmonary tox-
icity. In this study we used well characterized UfCPs
containing >96% elemental carbon [28] as a surrogate to
address the direct toxicity of the carbon particle core
without contributing effects of organic compounds or
metals.
Scientific statements of American Heart Association
[29] as well as extensive review by Gold and Mittleman
[30] discussed in detail the higher risk for cardiovascular
mortality due to PM exposure for few hours to weeks.
There is ample evidence from epidemiological studies
showing the elevated risk of myocardial infarction (MI),
stroke, arrhythmia, reduced heart rate variability (HRV),
and increased blood pressure (BP) following exposure in
susceptible individuals [29]. Gold and Mittleman [30]
and Nemmar et al. [11] have further described several
plausible pathological mechanisms of pollutant mediated
CVDs. These includes pulmonary and/systemic inflam-
mation, oxidative stress, alteration in prothrombotic and
coagulation pathways, vasoconstriction and altered BP,
vascular dysfunction and progression of atherosclerosis.
Researchers have also correlated variety of health effects,
particularly respiratory and cardiovascular impairments,
in response to the size and/or chemical composition of
PM and population characteristics (age, genetic predis-
position, pre-existing conditions). However, the under-
lying pathophysiological features which predispose an
individual to cardiovascular impairments following ex-
posure to air pollutants such as PM are still not well
elucidated.
Previously we detected that 24 h inhalation exposure
of UfCP serving as surrogates for combustion derived
UfCP in adult spontaneously hypertensive rats (age:
6 months; SHRs) cause cardiovascular impairments
without detectable pulmonary inflammation [31]. Based
on reported epidemiological observations and our pre-
vious findings we hypothesized that cardiovascular com-
promised elderly individuals are more susceptible and
are at higher risk to cardiovascular impairments fol-
lowing UfCP exposure compared to younger com-
promised or healthy individuals. Thus, in this study we
investigated the cardiovascular effects on aged SHRs
(12 months) following UfCP exposure under similar con-
ditions as previously described [31]. Furthermore, we
compared the findings to our previous findings so as to
identify the potentially susceptibility attributes (age/pre-
existing complications/higher disease burden) that can
lead to increased risk of UfCP mediated health effect.
Using comparable UfCP concentration, we detected sig-
nificant pulmonary neutrophilic influx along with cyto-
kine release in aged SHRs, which might be responsible
for ultimate exacerbation of the observed cardiovascular
impairments.
Upadhyay et al. Particle and Fibre Toxicology 2014, 11:36 Page 3 of 18
http://www.particleandfibretoxicology.com/content/11/1/36Results
Aged SHRs served as their own control and were ex-
posed first to filtered air and 4 weeks later to UfCP for
24 h to assess the effect on cardiac performance using a
radio telemetric system. The 4 weeks time gap between
control and exposure experiments was chosen to ensure
elimination of any possible effect of clean air exposure
on SHRs. Cardiac effects were most pronounced on the
1st and 2nd recovery day. CVD related biomarkers were
further analyzed at the target site (lung) and systematically
(heart and blood) in animals without telemetric implant
on the 1st and 3rd recovery days following 24 h exposure
to UfCP to assess inflammation, oxidative stress, endo-


































































Baseline Exposure Recov. 1
Figure 1 Circadian rhythmicity of physiological and behavioral param
representative diastolic blood pressure (dBP), systolic blood pressure (sBP),
baseline, exposure and recovery periods of a single SHR rat. The gray segm
parameter represents an average of 10-minutes data segments.significant alterations were observed on 3rd recovery day,
all data presented are from the 1st recovery day.
Cardiophysiological response in aged SHRs assessed by
radio telemetry
Baseline conditions
Systolic and diastolic arterial blood pressure (sBP and dBP
respectively), HR, body temperature (T), and activity level
(Act) of a representative aged SHR for the time course of
baseline (day 0), exposure (day 1), and recovery (day 2–5)
periods at 10-minutes data segments are shown in
Figure 1. Similar responses have been also observed
among all other animals. The data reflects typical circa-























Recov. 2 Recov. 3 Recov. 4
eters of spontaneously hypertensive rats (SHRs). The figure shows
heart rate (HR), body temperature (T) and physical activity (Act) during
ents indicate the dark periods (night time). Each data point of every
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HR, T, and Act values during the dark periods. The fin-
dings are in accordance to our previous observations in
adult SHRs [31]. Comparison of baseline values of cardio-
vascular parameters (mBP, HR, T, Act,) before clean air or
UFP exposure in aged SHRs revealed no significant altera-
tions despite the 4 week time gap (Figures 1, 2a and b;
Table 1).
Cardiovascular response to UfCP exposure
mBP were increased by 8 mmHg i.e. ~4.4% (p < 0.05) in
UfCP exposed aged SHRs (control: 181 ± 1.5; exposed:
189 ± 1.8 mmHg) on the 1st day of recovery and re-
turned to baseline levels on the 3rd day of recovery
(Figure 2a). This significant increase of mBP (p < 0.05) is
due to the concurrent increase in sBP (control: 208 ± 2.0;
exposed: 213 ± 1.7 mmHg) and dBP (control: 154 ± 2.1;
exposed: 155 ± 3.0 mmHg) with the effect on sBP being
more pronounced.
In contrast to the response in BP, HR responded with
a lag of one day similar to our previous observation in
adult SHRs [31]. However significant increase of HR
was detected only on the 2nd day of recovery. HR in-
creased by 21 bpm (p < 0.05) i.e. ~6.3% in exposed SHRs











































Figure 2 Blood pressure (BP) and heart rate (HR) changes in spontane
(UfCP) exposure compared to control. a. Mean blood pressure (mBP) inc
exposed SHRs compared to control. b. HR responded with a lag of one da
in UfCP exposed SHRs compared to control. It reached baseline values on
(mean ± SE) of control (white) and exposed (black) groups. Each bar repres
periods/rat) × 7 rats. (n = 7/experimental group; *indicates p < 0.05).baseline level on the 3rd day of recovery (Figure 2b).
UfCP exposure did not affect body temperature or ac-
tivity level of the animals.
Standard deviation of normal adjacent sinus intervals
(SDNN), a measure of the overall HRV was decreased
by ~36% during the 1st (control: 1.15 ± 0.07; exposure:
0.81 ± 0.01 unit) and 2nd (control: 1.03 ± 0.06; exposure:
0.77 ± 0.05 unit) recovery days (Figure 3). The square root
of the mean of squared differences between adjacent nor-
mal to normal intervals (RMSSD) and the low-frequency
to high-frequency ratio (LF/HF) showed a comparable re-
sponse as SDNN but reached statistical significance only
at the 4th day of recovery (Figure 3). Similar response has
been observed previously in UfCP exposed adult SHRs.
No individual changes in absolute LF (baseline: 20.0 ±
2.0 nu; 1st recovery day: 16.7 ± 3.0 nu; 2nd recovery day:
16.9 ± 3.3 nu) and HF (baseline: 68.2 ± 4.9 nu; 1st recovery
day: 70.0 ± 6.8 nu; 2nd recovery day: 67.0 ± 7.3 nu) were
observed. However, a significant decrease in LF/HF ratio
by 29% was observed in exposed SHRs on the fourth re-
covery day (control: 1.0 ± 0.1; exposure: 0.71 ± 0.08 unit,
(p < 0.05). The observed transient increase in HR asso-
ciated with overall decrease in HRV (i.e. SDNN) suggests
an altered sympatho-vagal balance in response to UfCP
exposure in aged SHRs.Days
 1 Recov. 2 Recov. 3 Recov. 4
* *
ously hypertensive rats (SHRs) following ultrafine carbon particle
reased by 8 mmHg (4.4%) on the 1st recovery day in the UfCP
y and exhibited an increase on the 2nd recovery day by 21 bpm (6.3%)
the 4th recovery day. The vertical bars represent arithmetic mean values
ents a combined mean value of: (72 10-minutes segments/12 h dark
Table 1 Baseline cardiovascular parameters of aged spontaneously hypertensive rats (SHRs, n = 7) in 4 weeks time gap
before clean air exposure (12 months) or Ultrafine carbon particle (UfCP)-exposure (13 months)
Cardiovascular parameters Baseline clean air exposure (12 months) Baseline UfCP-exposure (13 months)
Mean blood pressure (mBP, mmHg) 177 ± 1.8 179 ± 1.7
Heart rate (HR, bpm) 322 ± 3.7 317 ± 3.1
Body temperature (T, °C) 38.1 ± 0.1 37.9 ± 0.2
Activity (Act, event count) 54.1 ± 2.5 53.8 ± 4.1
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Bronchoalveolar lavage
(BAL) fluid of aged SHRs was assessed on 1st and 3rd days
of recovery following 24 h UfCP exposure based on the
observed alterations in cardiac performance. Pulmonary
inflammation has been observed only on the 1st recovery
day in UfCP exposed aged SHRs (Figure 4a and b). Total
BAL cell count increased by 41% (control: 11.6 ± 1.3;
exposed: 16.4 ± 2.2 1/ml × 106 cells, p < 0.05) and poly-













































Figure 3 Relative changes in time domain and frequency domain me
hypertensive rats (SHRs) following ultrafine carbon particle (UfCP) ex
(HR). HRV was decreased by ~36% in UfCP exposed SHRs during the 1st an
horizontal lines are used to highlight the relative changes. Each bar represe
period/rat) × 7 rats. (n = 7/experimental group; *indicates p < 0.05). SDNN:
root of the mean of squared differences between adjacent NN intervals. LF
0.75 Hz) and high-frequency bands HF: 0.75 Hz to 2.5 Hz).0.1; exposed: 1.3 ± 0.2 1/ml × 106 cells, p < 0.05) in the BAL
fluid of UfCP exposed SHRs compared to control while
lymphocytes remained unchanged (Table 2). The levels of
the proinflammatory cytokine interleukin 6 (IL6, Figure 4c)
was increased by 25% in UfCP exposed aged SHRs on the
1st recovery day (control: 92 ± 2.8; exposed: 115 ± 3.4 pg/ml,
p < 0.05). Tumor necrosis factor α (TNFα) levels as well as
parameters indicating tissue integrity like total protein,
albumin concentration, γ-Glutamyltransferase (GGT),
N-acetyl glucosaminidase (NAG), assessed in the BALs
Recov. 2 Recov. 3 Recov. 4
*
*
asurements of heart rate variability (HRV) in spontaneously
posure compared to control. HRV paralleled changes in heart rate
d 2nd days of recovery period as indicated by altered SDNN. Dotted
nts a combined mean value of: (12 5-minutes segments/12 h dark
standard deviation of normal to normal (NN) intervals. RMSSD: square
/HF: ratio of the absolute powers in the low-frequency (LF: 0.20 Hz to
ab
c
Figure 4 Bronchoalveolar lavage (BAL) fluid cell differentials and interleukin 6 (IL6) concentrations in ultrafine carbon particle (UfCP)
exposed spontaneously hypertensive rats (SHRs) compared to control on 1st recovery day. a. Total cell numbers in the BAL fluid of UfCP
exposed SHRs was increased by 41% compared to control (control: 11.6 ± 1.3; exposed: 16.4 ± 2.2 1/ml × 106 cells, p < 0.05). b. Polymorphonuclear
neutrophils (PMN) in the BAL fluid of UfCP exposed SHRs also increased by 58% compared to control (control: 0.82 ± 0.1; exposed: 1.3 ± 0.2 1/ml × 106
cells, p < 0.05). c. IL6 concentration in BAL fluid of UfCP exposed SHRs increased by 25% compared to control. Data are represented as mean ± SE.
(n = 6/experimental group; *indicates p < 0.05; white bar: control; black bar: exposed).
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in UfCP exposed SHRs compared to control. Transcript
levels of TNFα and macrophage inflammatory protein 2
(MIP2) were also not altered in the lung tissue.
UfCP mediated direct effect on pulmonary and
cardiac tissue
Histopathology
Histopathological analysis of the lung and heart revealed
no changes due to UfCP exposure in aged SHR rats
compared to control (data not shown). Fibrotic foci
(typical for SHRs) were noted in the heart but no indica-
tions of exposure related inflammatory reaction or car-
diomyopathy was observed.
Lung transcript analysis
Transcript profiling of markers associated with oxidative
stress (hemeoxygenase 1: HO1), endothelial activation
(endothelin 1: ET1; endothelin receptor A and B: ETA andETB), and coagulation cascade (tissue factor: TF and plas-
minogen activator inhibitor-1: PAI-1) were assessed in the
lungs of UfCP exposed aged SHRs compared to control
on 1st and 3rd recovery day (Figure 5a, b, c, d, e and f)
using quantitative real time polymerase chain reaction
(qRT-PCR). Transcripts of HO1 (2.0 fold), ET1 (1.5 fold)
and ETA (1.7 fold) were significantly (p < 0.05) increased
in UfCP exposed aged SHRs on 1st recovery day com-
pared to control whereas at 3rd recovery day HO-1 ex-
pression almost returned to control levels. Transcripts
of ETB were reduced in UfCP exposed SHRs on 1st re-
covery day by 0.5 fold (p < 0.05) whereas on 3rd recovery
day it remained unchanged. In contrast, transcripts of
PAI1 were significantly reduced (0.4 fold, p < 0.05) in
UfCP exposed SHRs on 3rd recovery days compared to
control. TF was increased on 1st recovery day (1.7 fold,
p < 0.05) but reduced (0.5 fold, p < 0.05) on 3rd recovery
day in UfCP exposed SHRs compared to control
(Table 2).
Table 2 Comparison of ultrafine carbon particle (UfCP) induced cardiovascular and inflammatory effects and
alterations of hematological parameters
Matrix Adult SHRs (Age: 6–7 months)
(Upadhyay et al. [25]
Aged SHRs
(Age: 12–13 months)
1st-3rd recovery day 1st recovery day
Cardiovascular Control UfCP exposed Control UfCP exposed
BP (mmHg) 176 ± 2.0 182 ± 2.1 ↑ (3.4%) 181 ± 1.5 189 ± 1.8 ↑ (4.4%)
HR (bpm) 328 ± 3.5 345 ± 3.5 ↑ (5.2%) 331 ± 3.2 352 ± 3.4 ↑ (6.3%)
SDNN 1.08 ± 0.05 0.77 ± 0.03 ↓ (30%) 1.15 ± 0.07 0.81 ± 0.01 ↓ (36%)
BAL
Total Cells (×106/ml) 3.7 ± 0.2 4.7 ± 0.2 11.6 ± 1.3 16.4 ± 2.21 ↑ (41%)
PMN (×106/ml) 0.3 ± 0.1 0.4 ± 0.1 0.8 ± 0.1 1.3 ± 0.2 ↑ (58%)
IL-6 (pg/ml), 83 ± 6.2 92 ± 4.1 92 ± 2.8 115 ± 3.4 ↑ (25%)
TNF-alpha (pg/ml) Not detectable Not detectable 20.0 ± 2.0 24.4 ± 2.6
NAG 5.3 ± 0.1 5.8 ± 0.1 4.5 ± 0.9 3.5 ± 0.2
Hematology
WBC (.103 cells/μl) 6.19 ± 0.4 5.79 ± 0.5 5.27 ± 0.7 5.57 ± 0.21
PLT (103 cells/μl) 436 ± 30.2 443.8 ± 48.4 379.5 ± 50.1 456.7 ± 25.6 ↑ (20%)
Hematocrit 44.8 ± 0.8 43.8 ± 2.1 43.6 ± 1.4 44.1 ± 0.4
Thrombocrit (%) 0.51 ± 0.04 0.39 ± 0.05 0.38 ± 0.04 0.42 ± 0.02
Neutrophil (%) 48.9 ± 2.2 39.2 ± 2.8 49.8 ± 4.04 43.9 ± 1.5
Lymphocyte (%) 43.3 ± 3.1 56.3 ± 2.9 43.4 ± 4.4 49.3 ± 1.7
Systemic
HPT (serum, mg/dl) 300 ± 17 309 ± 20 611 ± 17 710 ± 20 ↑ (16%)
CRP (serum, μg/ml) 92 ± 3.8 94 ± 3.0 132.7 ± 10.2 209 ± 4.4 ↑ (58%)
Fibrinogen (Plasma, mg/dl) 190 ± 11.4 198 ± 5.2 191 ± 5 217 ± 8.0 ↑ (13.6%)
Plasma renin concentration (PRC) 1st recovery day 2nd recovery day
55 ± 7.0/120 ± 14.0 ↑ 52 ± 4.0/70 ± 8.0 ↑ 50 ± 13.4 39 ± 9
Lung Transcript analysis
(Expression in UfCP exposed SHRs compared to control)
1st recovery day 3rd recovery day 1st recovery day
HO-1 NS ↑2.5 fold ↑2.0 fold
ET-1 NS ↑6.0 fold ↑1.5 fold
ET-A NS ↑2.5 fold ↑1.7 fold
ET-B NS ↑2.5 fold NS↓0.5 fold
PAI-1 ↓ ↑2.5 fold NS↓0.4 fold (3rd day)
TF NS ↑2.5 fold ↑1.7 fold
Cardiac Transcript analysis
(Expression in UfCP exposed SHRs compared to control)
1st recovery day 3rd recovery day 1st recovery day
HO-1 NS ↓2.0 fold NS
ET-1 NS NS ↑1.5 fold
ET-A NS NS NS
ET-B NS NS NS
PAI-1 NS NS NS
TF NS NS NS
Parameters are displayed for adult (6–7 months [25]) and aged (12–13 months) spontaneously hypertensive rats (SHRs) Adult SHRs data are adapted
from Upadhyay et al. [31]. WBC: White Blood Cells; PLT: Total Platelet; BP: blood pressure; HR: heart rate; BAL: broncho alveolar lavage; IL6: interleukin 6; TNF:
tumor necrosis factor alpha; NAG: N-acetyl glucosaminidase; HPT: haptoglobin; CRP: C reactive protein. NS not significant. ↑: significantly increased; ↓: significantly
decreased; Adult SHRs UfCP mediated effect was mostly observed with a lag of 1–3 days, whereas UfCP mediated immediate effect was observed on aged SHRs.





Figure 5 Expression analysis of lung transcripts associated with oxidative stress, endothelial activation and coagulation cascade in
ultrafine carbon particle (UfCP) exposed spontaneously hypertensive rats (SHRs) compared to control on 1st (24 h) and 3rd (72 h)
recovery day using quantitative real time polymerase chain reaction (qRTPCR). a. Transcript levels of Haemoygenase 1 (HO1) was significantly
increased in UfCP exposed SHRs on 1st recovery day compared to control whereas at 3rd recovery day it remained unchanged. b. Transcript levels of
endothelin 1 (ET1), was significantly increased in exposed SHRs on 1st recovery day compared to control whereas at 3rd recovery day it remained
unchanged. c. Transcript levels of endothelin receptor A (ETA) was significantly increased in UfCP exposed SHRs on 1st recovery day compared to
control whereas at third recovery day it remained unchanged. d. Transcript levels of endothelin receptor B (ETB) was significantly reduced in UfCP
exposed SHRs on 1st recovery day compared to control whereas at 3rd recovery day it remained unchanged. e. Transcript levels of plasminogen
activator inhibitor-1 (PAI1) were significantly reduced in UfCP exposed SHRs on both 1st and 3rd recovery days compared to control. f. Transcript levels
of tissue factor (TF) were significantly increased on 1st recovery day and significantly reduced on 3rd recovery day in UfCP exposed SHRs compared to
control. Data are represented as mean ± SE. (n = 6/experimental group; *indicates p < 0.05; white bar: control; black bar: exposed.
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Transcript expression of HO1, ET1, ETA, ETB, PAI1
and TF were also measured in the heart of UfCP ex-
posed SHRs on the 1st and 3rd day of recovery compared
to control. Only ET1 was induced by 1.5 fold (p < 0.05)
in the cardiac tissue of UfCP exposed SHRs on both 1st
and 3rd recovery days (Figure 6; Table 2).bSystemic response
Haematology
The complete blood cell count (total red and white blood
cell, haematocrit, platelets, PMN, and lymphocytes) were
measured in UfCP exposed aged SHRs on 1st and 3rd days
of recovery compared to control (Table 2). Platelet num-
bers were significantly increased by 20% in UfCP exposed
SHRs compared to control (control: 380 ± 50; exposed:
457 ± 25 ×103 cells/μl, p < 0.05) on the 1st day of recovery.
Other cell counts remained unaffected.cAcute phase proteins
Levels of C-reactive protein (CRP), haptoglobin (HPT)
and fibrinogen were increased in the serum or plasma of
UfCP exposed SHRs compared to control on 1st recovery
day (Figure 7; Table 2). CRP concentration increased by
58% (~1.6 fold, p < 0.05) in the serum (control: 132.7 ±
10.2 exposed: 209 ± 4.4 μg/ml); HPT concentration in-
creased by 16% in the serum (control: 611 ± 17; exposed
710 ± 20 mg/dl, p < 0.05); and fibrinogen concentration
increased by 13.6% (control: 191 ± 5; exposed 217 ±
8.0 mg/dl, p < 0.05) in plasma.Figure 6 Expression analysis of endothelin 1 (ET1) heart
transcript level in ultrafine black carbon particle (UfCP)
exposed spontaneously hypertensive rats (SHRs) compared to
control on 1st (24 h) and 3rd (72 h) recovery day using
quantitative real time polymerase chain reaction (qRTPCR).
Transcript levels of ET1 were significantly increased in UfCP exposed
SHRs on both 1st and 3rd recovery days compared to control. Data
are represented as mean ± SE. (n = 6/experimental group; *indicates
p < 0.05; white bar: control; black bar: exposed).
Figure 7 Expression of acute phase protein in serum and
plasma of ultrafine carbon particle (UfCP) exposed
spontaneously hypertensive rats (SHRs) compared to control
on 1st recovery day. a. C-reactive protein (CRP) concentration
increased by 58% (~1.6 fold) in the serum of UfCP exposed SHRs
compared to control. b. Haptoglobin concentration in the serum of
UfCP exposed SHRs after increased by 16% compared to control.
c. Fibrinogen concentration in plasma of UfCP exposed SHRs increased
by 13.6%. Data are represented as mean ± SE. (n = 8/experimental
group; *indicates p < 0.05; white bar: control; black bar: exposed).Effect on renin-angiotensin system (RAS)
Based on the cardiovascular response (altered BP and
HR) in UfCP exposed aged SHRs plasma rennin and
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employing specific radioimmunoassay as described pre-
viously [32]. No effect on RAS was observed due to
UfCP exposure in aged SHRs.
Discussion
Inflammation, vascular reactivity, and atherosclerotic ef-
fects are the main contributing events for ambient ultra-
fines and UfCP exposure mediated onset of cardiovascular
impairments [33-36]. In this study we have shown that
UfCP inhalation exposure of aged SHRs results in an im-
mediate increase in the levels of inflammatory cells and
IL-6 in the BAL fluid and increased pulmonary expression
for markers of inflammation, vasoconstriction and coagu-
lation. The detected pulmonary response may be linked to
the response observed on the systemic level, as evidenced
by changes of cardiovascular parameters (BP, HR, HRV)
and the increases in inflammatory mediators at the local
and/or systemic level, the activation of blood coagulation
mechanisms as evidenced by increased TF, fibrinogen,
platelet count and acute phase reactant (CRP, HPT). Our
findings further point towards the potential susceptibility
characteristics and plausible molecular mechanisms which
might increase the cardiovascular risk to aged SHRs fol-
lowing UfCP exposure.
UfCP induced pulmonary and systemic effect on
aged SHRs
SHRs have been widely used as an ideal animal model of
hypertension to study the cardiovascular disease [37]. As
the total peripheral resistance increases from normal to
elevated levels, the SHRs progresses into the established
hypertension state, typically, between the 4th and 6th
months of age [38]. Hypertension is a commonly consi-
dered condition by epidemiologists in stratified analyses
while studying the association between short-term PM
exposure and cardiovascular-impairments. However, it is
unclear whether preexisting hypertension modifies such
associations. One study conducted in Utah found no evi-
dence of increased risk for acute ischemic heart disease
(IHD) events following PM2.5 exposure among individ-
uals with preexisting hypertension compared with those
without hypertension [39]. In contrast, Peel et al. [40]
found that the presence of preexisting hypertension re-
sulted in an increased risk of CVD with PM10 exposure.
Similarly Rueckerl et al. [41] summarized the existing
positive association between ambient air pollution and
increased ischemic events in susceptible individuals. The
potential effect of hypertension on the manifestation of
ambient UfCP mediated cardiovascular effects is sup-
ported by a toxicological study conducted in a rat model
of hypertension [42]. Another study demonstrated that
concentrated ambient particles (CAPs) exposure resulted
in higher mean arterial pressure compared to controls[43]. These experimental findings clearly indicate an as-
sociation between PM2.5 exposure and hypertension
leading to worsening of hypertension-related cardiovas-
cular outcomes observed in epidemiological studies.
A series of epidemiological and in vivo studies have
shown that exposure to UfCP is associated with pulmon-
ary and/or systemic inflammation caused by deposition
of particles in the alveoli or due to the translocation of
fine particle into the systemic circulation [29,44-47] as
the particle get smaller. Recently Kreyling et al. [17] have
reported that translocation of UfCP across the air-blood
barrier and accumulation in the secondary organs or tis-
sues (heart, blood) are highly dependent on the particle
specific surface area [17]. However Kreyling et al. [17,45]
have also shown that particle mediated adverse health
effects in secondary organs (cardiovascular system) are
not only the result of particle translocation following
exposure (inhalation/instillation); rather chemical com-
position, physical characteristics or particles (size, sur-
face charges) are the important determinant to induce
adverse health effect (cardiovascular impairments). Mul-
tiple mechanisms such as particle induced local and
systemic inflammatory response, activation of oxidative
stress, increased blood coagulation and endothelial dys-
function are likely to be involved in UfCP mediated car-
diovascular events [48-50]. Alternatively, it is possible
that increased sympathetic tone might also contribute to
cardiophysiological response following an acute expo-
sure to UfCP.
Increased BP and HR in association with HRV in aged
SHRs are consistent with epidemiological and experimen-
tal observations. Significant decrease of SDNN on 1st and
2nd recovery day following 24 h exposure to UfCP repre-
sents overall depression of HRV, which reflects autonomic
modulation of rhythmic heart rate. Similar response was
reported by Devlin et al. [51] in a controlled experiment
where significant decrease in HRV was observed in elderly
individuals immediately after exposure to concentrated
ambient particles. Consistent with our result, in another
controlled study with predisposed (asthmatic) individuals
Power et al. [52] reported significant decrease of SDNN
immediately following exposure to particles and ozone.
Measurement of HRV as 5 minutes SDNN decreased by
18-26% during the 10 minutes resting period in 11 healthy
aged school crossing guards following exposure to heavy
traffic area in their morning shift [53]. All these findings
are highly comparable with our present result showing
overall significant reduction of HRV in aged SHRs after
exposure to UfCP. Additionally significant reduction of
LF/HF ratio (29%) in aged SHRs is also supported by the
finding from Timonen et al. [54]. The study involving
pooled analysis of three centers (Erfurt, Amsterdam and
Helsinki) demonstrated 13.5% reduction of LF/HF with a
lag of 2 days following exposure to ambient PM2.5 [54].
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changes in HRV is not fully known, reduced HRV has
been associated with increased risk for developing co-
ronary heart disease and to sudden cardiac death.
Increased level of BAL IL-6 in aged SHRs immediately
following UfCP exposure may induce the risk of both
venous and arterial thrombosis by increasing expression
of tissue factor, fibrinogen and platelet activation [48].
The association between IL-6 and ischemic heart disease
is well documented and is substantially attributable to
the effects of IL-6 on atherosclerosis plaque formation.
Mutlu et al. [48] thus provided a potential mechanism
linking ambient PM exposure and thrombotic events. In
that study authors have further shown that the induced
pulmonary cytokine production (IL-6 from alveolar mac-
rophages) following PM exposure might be responsible
for increased intravascular thrombin formation, and ac-
celerated arterial thrombosis. In a follow-up study Scott
Budinger et al. [49] concluded that PM-induced lung
inflammation or IL-6 generation is sufficient for the acti-
vation of coagulation and impaired fibrionolysis locally
(lung) as well as systematically (blood, cardiac tissue
etc.). IL-6 also induces the release of acute phase reac-
tant (like CRP, HPT and fibrinogen) from hepatocytes
[48,55]. HPT, fibrinogen, and CRP are the typical acute
phase protein that are induced during inflammation and
are used clinically as an indicator of the presence and
intensity of inflammation. Increased IL-6, CRP, and fi-
brinogen levels are highly associated with increased risk
of mortality from cardiovascular diseases as evidenced
by Riediker et al. [56]. They also detected increased CRP
levels in highway patrol officers after exposure to traffic-
related PM. Similar correlation between PM exposure
and serum CRP levels have been reported by Rueckerl
and colleagues among predisposed men [57]. Fur-
thermore Bourdon et al. [26] reported that inflammatory
signaling molecules like IL-6 or CRP are involved in
pulmonary injury and the trigger of the acute phase re-
sponse (APR) following exposure to carbon black nano
particles (CBNP). This in turn may further increase sus-
ceptibility to cardiovascular impairments.
A study by Ridker et al. [58] reported hs-CRP as the
strongest univariate and only multivariate predictor for
the risk of cardiovascular events in women among twelve
markers measured. The median hs-CRP levels of women
with cardiovascular events was 0.42 mg/dl whereas among
women free of cardiovascular events the hs CRP levels
were 0.28 mg/dl, i.e. 50% induction in diseased state. The
fact that we observed a comparable increase in CRP levels
(58%) in exposed aged SHRs supports the relevance of our
findings for cardiovascular events. Most of the animal
studies also provide strong evidence of increased CRP
levels following PM exposure [59,60]. Significantly stron-
ger PM-induced CRP responses were observed in SHRs,compared to rats with normal blood pressure [61].
Recently Higashisaka et al. [60] have shown a significant
increase of CRP and HPT in BALB/c mice treated with
silica nanoparticles. Consistent to the findings of other re-
searchers [60,61], we also found significant induction of
CRP, fibrinogen and HPT in aged SHRs following in-
halation exposure to UfCP. We have previously shown
that CRP and HPT were not affected in adult SHRs after
exposure to UfCP (Table 2; [31]). Recently Farina et al.
[62] reported that the translocation of inflammatory me-
diators, such as cytokines and UfCP from lungs to blood-
stream might trigger a systemic reaction resulting in
endothelial activation, oxidative stress and subsequent
cardiovascular response. The significant induction of sys-
temic acute phase reactant (CRP, HPT) and coagulation
markers (fibrinogen and platelet) might be associated with
UfCP mediated release of IL-6 from alveolar macrophages
as well as translocation of UfCP from lung to the systemic
circulation as previously suggested by several researchers
[46,48,49,62]. Following 2 h controlled exposure of 19 pre-
disposed subjects (type II diabetes) to elemental carbon
UfCP, Stewart et al. [35] reported transient activation of
blood platelets, with possible activation of blood leuko-
cytes and vascular endothelium. From this study authors
have further inferred that the observed transient and small
effect can even lead to acute vascular insult with pro-
thrombotic consequences that could increase the risk and
susceptibility for immediate UfCP induced cardiovascular
events among elderly individuals with preexisting compli-
cations like hypertension, diabetes [5,6].
Induction of ET(A) along with induced pulmonary ex-
pression of ET-1 in aged SHRs after UfCP exposure may
cause pulmonary microvascular endothelial dysfunction.
Holcox et al. [63] suggested endogenous endothelin by
stimulation of ET(A) receptor contribute to basal con-
strictor tone and endothelial dysfunction. Chauhan et al.
[64] have shown up-regulation of ET-1 in human pulmo-
nary epithelial cells (A549) following exposure to the
ambient PM. Our findings of ET-1 up-regulation in UfCP
exposed aged SHRs are in agreement with Karthikeyan
et al. [65], who observed induction of ET-1 in association
with pulmonary inflammation and oxidative stress in rats
after exposure to diesel exhaust particle. Interestingly, re-
duced ET(B) expression have been observed in UfCP ex-
posed aged SHR lungs. Kobayshi et al. [66] suggested that
down-regulation of ET(B) receptor, but not ET(A) recep-
tor, occurs in the congestive rat lung. Kobayshi et al. [66]
further proposed that down-regulation of lung ET(B) re-
ceptors partially contributes to the significant increase in
ET-1 and may be involved in the progression of pulmon-
ary injury in aged SHRs. Indeed, increased level ET-1 in
UfCP exposed pulmonary tissue may increase oxidative
stress, pulmonary neutrophils activation after UfCP expo-
sure. In the heart, ET-1 is synthesized by cardiomyocytes,
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cardiac fibroblasts to produce extracellular matrix pro-
teins thus promoting myocardial fibrosis [67]. Hence, the
increased expression of ET-1 in cardiac tissue of aged
SHRs might be responsible for alteration of cardiac
physiological measures.
In the cardiac tissue of aged SHRs, over expression of
only ET-1 might be an indirect effect of systemic inflam-
matory changes. However, Bourdon et al. [68] recently
suggested that CBNP or UfCP mediated systemic inflam-
matory effects are likely responsible events for cardio-
vascular events without any direct alteration of gene
expression in the heart tissue. They showed that gene
expression in the heart remained unaffected by CBNP
exposure in spite of substantial alteration of pulmonary
and hepatic gene expression along with increased plasma
cell adhesion molecules and PA-I. However the distinct
differences between present study and Bourdon et al.
[68] study should be accounted. As for example, differ-
ent species (healthy mice versus compromised rats) and
UfCP instillation of aggregated UfCP at a relative high
dosage of 162 μg for mice versus inhalation over 24 h in
our study with a cumulative estimated dose of 31 μg in
rats (tidal volume 2 ml, breathing frequency 120 min−1,
respiration 0.345 m3/day, 180 μg/m3 UfCP, deposition ef-
ficiency 50% [69]).
Previously we have shown an induction of HO-1 in
adult SHRs with a lag of 3 days following 24 h exposure
to UfCP [31]. In this study involving aged SHRs, the
significant induction of lung HO-1 occurred imme-
diately after exposure to UfCP suggests an earlier onset
of oxidative stress. Overproduction of reactive oxygen
species (ROS) under pathophysiologic conditions forms
an integral part of the development of cardiopulmonary
disease, and in particular atherosclerosis plaque for-
mation [70,71]. Increased expression of HO-1 is an indi-
cation of oxidative stress, and therefore assessment of
HO-1 levels may assist in identifying the susceptible
individuals for UfCP exposure related adverse health
effects [72]. The induction of HO-1 in the lung might
suggest an induction of oxidative stress from UfCP
exposure [73].
In this study we detected inflammatory effects, cardio-
vascular and acute phase responses after exposure to a
rather low mass dose of 31 μg UfCP deposited in the rat
lungs throughout the 24 h exposure (see calculation
above). Based on these estimates biomarkers of inflam-
mation and acute phase response are increased at a con-
siderable low mass dosage. However, for UFP the large
particle surface area available for interaction with bio-
logical materials rather than the particle mass has turned
out to be the key determinant of toxicity [74]. Accor-
dingly, an approximation of the UfCP surface area de-
posited in the rat lung reveals 0.024 m2 throughout the24 h exposure (respiration of 0.345 m3/day, 0.139 m2
UfCP surface/m3, deposition efficiency 50% [69]). If a
human would inhale the applied UfCP at the same con-
centration for one day, the lung burden would be
1.46 m2 in terms of UfCP surface area or 1.89 mg in
terms of mass (15 m3/day inhaled air, deposition effi-
ciency 70%, [75]. However, a rough estimate for urban
sites of high air pollution close to major traffic roads
suggests the daily lung burden for urban residents to be
about 0.015 m2/day or 0.14 mg, assuming that UFPs in
urban air are derived mainly from mobile sources with a
specific surface area comparable to DEP (110 m2/g) and
a UFP mass concentration of 13 μg/m3 [76]. Thus, the
UfCP surface area dose delivered experimentally to the
rat lung is comparable to that urban residents may
undergo. However, the alveolar surface area differs by a
factor of ~100 between the two species. Thus the experi-
mentally delivered particle surface area clearly exceeds
that estimated for urban residents. Considering the de-
posited UFP which may accumulate in the lung over
time [77,78], the experimentally delivered surface dose
under environmental conditions could be reached within
months thereby supporting the notion that biological ef-
fects in our experimental setting are detectable at a rela-
tive low dosage.
Comparison of susceptibility between aged and
adult SHRs
The term susceptible or sensitive population has been
used more generally to characterize the response of
human to air pollutants [6]. Collective evidence from
several epidemiological studies as well as control human
exposure and animal studies have identified certain cha-
racteristics which may lead to increased susceptibility to
air pollutant or UfCP mediated health risk [1,11]. They
include life stages, genetic polymorphisms, preexisting
conditions like hypertension, respiratory diseases, and
diabetic condition [5,6,35,79,80]. However, supporting
experimental evidence is required to identify the mecha-
nisms by which each of these factors change the sus-
ceptibility and leading to a higher degree of risk to
PM-related health effects in one population compared to
another.
We have previously shown that 24 h inhalation expos-
ure of adult SHRs to UfCP significantly increases HR
and BP with a lag 1–3 days without PMN influx [31]. In
contrast, under similar exposure conditions, transient
increases of HR with moderate pulmonary neutrophilic
influx were detected in healthy WKY rats [81]. In the
present study, we detected small but significant pulmon-
ary inflammation along with release of systemic acute
phase reactants (CRP, HPT) and induced coagulatory
pathways (fibrinogen, tissue factor) in aged SHRs fol-
lowing UfCP exposure. Previous studies have shown that
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flammation compared to WKY when exposed to com-
bustion source particles by inhalation [82,83]. It is
possible that at an older age, SHR respond more readily
to UfCP than at younger age with regards to the neutro-
philic inflammation.
Our earlier study involving adult SHRs showed in-
creases in BP and HR with marked increases in lung ex-
pression of vasoconstriction and clotting markers with a
lag of 1–3 days after UfCP in the absence of significant
pulmonary neutrophil influx [31]. The early induction of
these changes in aged SHR following 24 h exposure to
UfCP together with significant pulmonary neutrophil
influx and also systemic increases in thrombosis bio-
markers indicates that aged SHRs may experience
greater cardiovascular morbidity from exposure to UfCP
when compared to adult SHR and that there is likely a
shift in the time-lag, important to consider in epidemio-
logical studies. The biological significance of the disso-
ciation in the time course between aged and adult SHRs
cannot be directly inferred from our exposure scenario.
However, one may speculate that the diminished com-
pensatory antioxidant reserve in aged SHR may predis-
pose them to early expression of changes while in the
adult rats UfCP-induced changes might be countered for
a longer duration. A detailed comparison of all observed
parameters (cardiovascular, inflammatory) from aged
and adult SHRs following exposure to UfCP has been
provided in Table 2, which clearly indicates that aged in-
dividuals are showing more UfCP induced health impact
and a different response pattern than the predisposed
adult individuals or young healthy WKY rats [81]. In
line, epidemiological studies in some cities of Australia
and New Zealand by Barnett et al. [80] showed a signifi-
cant association between increased air pollution and
higher cardiovascular impairment related hospital ad-
mission of elderly individuals with IHD and MI which
were not apparent for younger individuals. Comparison
of cardiovascular response patterns in aged compro-
mised animals (i.e. SHRs) with healthy WKY rats [81]
and adult SHRs [31] suggests that aged hypertensive ani-
mals are more susceptible to UfCP that might have been
contributed due to their worsening cardiovascular com-
plications at an advanced age.
Compared to our previous study [31], rennin-angiotensin
concentration remained unaffected in aged SHRs follo-
wing exposure to UfCP. Aged SHR may differ from that
of adult SHR for their regulation of renin-angiotensin-
aldosterone system associated with advanced kidney da-
mage although renin-angiotensin concentrations remain
unaffected. UfCP exposure was associated with induction
of TF (1.5-fold) in the lungs of aged SHRs, which might
cause activation of coagulation cascade promoting throm-
bus formation and the risk of cardiac events [50,84]. Inadult SHRs, we previously reported induction of lung TF
following 72 h of UfCP exposure. Budinger and colleagues
[49] observed an IL-6 dependent increase in lung TF tran-
scripts following exposure to concentrated ambient parti-
cles. Comparison of our present findings (aged SHRs)
with previous observation (adult SHRs) are consistent
with a large body of epidemiological and clinical/toxico-
logical studies suggesting that elderly individuals with
preexisting pathophysiological conditions are likely more
vulnerable to PM mediated health effects [6,85].Conclusion
Exposure of aged SHRs to UfCP induced a neutrophilic
influx and an increased IL6 level in the lungs. This inflam-
matory response of the lungs is paralleled by a systemic
inflammation indicated by increased CRP, HPT, fibrinogen
levels, and oxidative stress as inferred from increased
HO-1 expression in the lung. Further, increased pul-
monary expression of endothelin and systemic markers of
blood coagulation are suggestive for a disturbed vasoregu-
lation and coagulatory homeostasis. Contemporaneous
cardiovascular impairments (induced BP and HR) in the
aged animals suggest the contribution of vasoconstrictive
and thrombogenic effects in observed physiological im-
pairment in the heart. The response we observed in aged
SHR differs from that of adult SHRs, in that UfCP expo-
sures mediated an increase in BP and HR occurred with-
out a traceable pulmonary and systemic inflammation
[31]. This suggests that aged SHRs are likely to be more
susceptible than the adult SHRs to UfCP mediated cardio-
vascular risks and that there is likely a differential time lag
for adult and aged rats. Based on our data, we cannot dis-
entangle the contribution of age versus advanced disease
in the observed systemic and cardiovascular effects.
Nevertheless, the complex response observed in the lungs
and on a systemic level in the aged, cardiovascular com-
promised animals provides further evidence for potential
mechanisms explaining the increased risk of particle me-
diated cardiac health effects in the cardiovascular compro-
mised elderly.Materials and methods
Animals
Aged male spontaneously hypertensive rats (SHR;
12 months, body weight: 411 ± 4.7 g; n = 15) were used
for the present study. Animals were housed under filtered
air and specific pathogen free (SPF) conditions at a mean
temperature of 22 ± 2°C, a mean relative humidity of 50 ±
5%, and a 12 h light–dark cycle (6 a.m. to 6 p.m. light on)
with pelleted feed and filtered water being supplied ad libi-
tum. Experimental protocols were approved by the Animal
Care and Use Committee of the Helmholtz Zentrum
München – German Research Center for Environmental
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(211-2531-88/2001).Ultrafine carbon particle generation and whole body
exposure chamber
The methodology of UfCP generation and the setup of
the whole body exposure system for rodent have been
previously described [31,81]. UfCP showed a mono-
modal number distribution in the exposure chamber
with a median particle size ± arithmetic SD of 31 ±
0.3 nm. Measured mass and number concentration was
180 μg m−3 and 9× 106 cm−3, respectively. This trans-
lates into a surface area concentration of 0.139 m2
(particle) m−3 (air) because the mass specific surface
area (according to the BET method) of the UfCP was
determined to be 807 m2 g-1. Based on the polydis-
persity of the particle distribution (geometric standard
deviation is 1.51) a median mass diameter of 46 nm is
calculated. An approximation of the dose deposited in
the rat lung reveals 31 μg UfCP or 0.024 m2 UfCP sur-
face areas throughout the 24 h exposure. This dose was
selected with respect to peak ambient UFP concentra-
tions which may accumulate a corresponding dose in
the lungs of healthy humans in a reasonable time, i.e.
within several months (see Discussion).Experimental design
The cardiophysiological responses, i.e. effects on HR
and BP were measured on aged SHRs (n = 7) following
24 h UfCP inhalation exposure using a radiotelemetry
system. Although BP and HR were increased only on
1st day of recovery, however, subsequent exposures were
conducted in additional, non-telemetry SHRs to obtain
blood, BAL and tissue samples on both 1st and 3rd day
of recovery following 24 h of exposure as in our pre-
vious study [31].
Each exposure used 16 SHRs, 8 animals were exposed
to filtered air (controls) while the other 8 animals were
exposed to UfCP for 24 h (exposed). In the first study,
animals were sacrificed in the morning of the 1st day of
recovery, similarly in a separate study another 16 ani-
mals were sacrificed 72 h or on 3rd day of recovery fol-
lowing 24 h exposure to UfCP. Prior to BAL collection,
blood samples of 8 SHRs were collected from retro or-
bital sinus for analysis of haematological parameters
and from the abdominal aorta for analysis of bio-
markers. Six animals were used to collect BAL and
tissue samples (heart and lung) for further assessment
of pulmonary and systemic response, the remaining 2
SHRs of each group were used for pulmonary and car-
diac histopathology. Animal distribution and sample
collection of the control group was similar to that of the
exposed group.Cardiophysiological analysis by radiotelemetry
Animal preparation (Surgical implantation)
The implantation of telemetric devices into the peritoneal
cavity of animals was performed as previously described
[31,81]. After 10 days of post surgical recovery, two days
(day -2 and day -1) acclimatization of animals in the expo-
sure chamber had been carried out prior to the actual data
recording cardiovascular response (BP and HR) reaches to
its baseline values. Data recording was then initiated and
continued for six days (Figure 1), that included a baseline
reading (day 0), exposure (day 1), and recovery period
readings (days 2–5).
Animal exposure
Individual animals served as their own controls similar to
our previous study [31]. Following 10 days of post surgical
recovery and 2 days of acclimatization in the exposure
chamber aged SHRs (n = 7) were primarily exposed to fil-
tered air (control) and 4 weeks later to UfCP by whole-
body exposure for 24 hrs. A time gap of 4 weeks was
chosen in between control (filtered air) and UfCP exposure
to ensure elimination of any possible effects of clean air
exposure as individual animals served as their own control.
However, comparison of baseline values between 12 and
13 months old SHRs indicate that cardiac performance
was not altered by the 4 week time gap between control
and exposure conditions (see baseline values in results).
Data acquisition
Cardiophysiological response before and after inhalation
exposure to UfCP was performed on 12 months old SHRs
(n = 7) by using radio telemetric system as described in
our previous study [31,81]. Briefly arterial BP, HR, T, and
Act of SHRs were continuously collected over 24 h/day,
throughout baseline, exposure and recovery periods. Ar-
terial blood pressure (sBP, dBP, and mBP) were determined
from the BP tracings on a beat to beat basis. For HRV
analysis, each 5-minutes ECG segment per hour was ran-
domly selected for 12 h dark period. Standard deviation of
all adjacent normal sinus NN intervals (SDNN) for each
of those 5-minutes segments were considered as overall
HRV. Additionally the square root of the mean of squared
differences between adjacent normal to normal intervals
(RMSSD) and the low-frequency to high-frequency ratio
(LF/HF) was determined, which reflects the balance of
cardiac parasympathetic tone and sympathetic activity, re-
spectively. The detailed methodology of HRV data analysis
is as described previously (81).
Assessment of UfCP mediated pulmonary inflammatory
response
BAL and lung tissue processing
BAL analysis was performed as described in our previous
studies [31,81]. One aliquot of whole BAL (n = 6) was used
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Coulter, Inc., Miami, FL), and a second aliquot was cen-
trifuged (Cytospin 2; Shandon, Astmoor, UK) to counts
cell differential. Macrophages, polymorphonuclear cells
(PMNs, or neutrophil), eosinophil, and lymphocyte were
counted using light microscopy (over 200 cells counted
per slide). The remaining BAL was centrifuged (1500 × g)
to remove cells, and the supernatant fluids were used
to analyze the protein, albumin, γ-Glutamyltransferase
(GGT), N-acetyl glucosaminidase (NAG) activity, IL-6 as
potential biological markers for pulmonary inflammation,
capillary leakage and lung injury. Furthermore, lung and
left ventricular tissues were snap frozen in liquid nitrogen
for later RNA extraction and RT-PCR for markers asso-
ciated with pulmonary inflammation, oxidative stress,
vasoconstriction and thrombosis (n = 6).
Pulmonary histopathology
Pulmonary histopathology was performed as previously
described [31,81].
Assessment of UfCP mediated effects on pulmonary and
cardiac tissue
Gene expression
Lung and cardiac total RNA was isolated using the RNeasy
(lung) or RNeasy fibrous tissue (heart) kits and protocols
from Qiagen. RNasin Plus (Promega), a broad spectrum
RNase inhibitor, was added to each sample immediately
after isolation from the tissue. Concentration and purity of
the RNA samples were determined with the NanoDrop
ND-100 spectrophotometer (NanoDrop Technologies). Ali-
quots of each sample were diluted to a concentration suit-
able for PCR stored at −80°C. Relative quantification of
gene expression was determined by real-time RT-PCR using
the Applied Biosystems Inc. model ABI 7900 HT Sequence
Detection System, as described previously [31]. Gene spe-
cific primers for control and target genes were purchased
from Applied Biosystems Incorporated [31]. SuperScript III
Platinum One-Step Quantitative RT-PCR System from Invi-
trogen reagent kit was used for expression assays. Reverse
transcription and amplification conditions were as follows:
53°C for 20-minutes, 95°C for 2-minutes, and 40 cycles at
95°C for 15 seconds and 60°C for 45 seconds. Data were an-
alyzed using ABI sequence detection software (SDS), ver-
sion 2.2. For each PCR plate, cycle threshold (Ct) was set to
an order of magnitude above background. For each individ-
ual sample, target gene Ct was normalized to a control Ct
to account for variability in starting RNA amount. Expres-
sion of each exposure group was quantified as fold differ-
ence over FA control, at the corresponding time point.
Cardiac histopathology
Cardiac histopathology was performed as previously de-
scribed [31,81].Assessment of UfCP mediated systemic response
To assess the UfCP mediated inflammatory response at
systemic level blood samples of each animal were col-
lected from retro orbital sinus (haematology) and from
abdominal aorta (biomarkers) on 1st and 3rd day of
recovery.
Haematology
500 μl of blood sample from retro orbital sinus of each
animal (n = 8) was collected in EDTA-Microvette for
hematological analysisusing haematology analyzer (Bayer
ADVIA 120, Germany).
Acute phase protein analysis
Blood samples collected from abdominal aorta (blood A,
n = 8) were separated citrate. Each citrated blood sample
was then centrifuged (at 2710 g) for 10-minutes (4°C) and
plasma samples were stored at −80°C until analyzed.
Fibrinogen concentration was measured in each citrated
plasma samples as previously described [86]. Serum
was collected from blood samples by centrifugation for
15-minutes (at 1300 g, 4°C). Serum CRP was measured
using the kit from DiaSorin Inc. (Stillwater, MN) and HPT
using the kit from Kamiya Biomedical Company (Seattle,
WA).
Renin/Angiotensin analysis: Renin, angiotensin I (Ang I)
and angiotensin II (Ang II) concentrations and activity
were measured from plasma following 24 h of exposure to
UfCP. For this purpose blood samples were collected from
abdominal aorta (n = 8) in a 5 ml falcon tube containing
mixture (140 μl/ml blood) of p-hydroxy-mercuribenzoic
acid (10 μl, Sigma), phenyl-methyl-sulfonyl-fluoride (10 μl,
Sigma), EDTA (50 μl), pepstatin A (20 μl, Sigma) and
o-phenanathrolin (50 μl, Merck). Measurements of renin
activity and concentration as well as angiotensin (I and II)
concentrations were assayed employing specific radio-
immunoassay, as previously described [32].
Statistics
After checking for the normal distribution assumption
the differences between exposure and control groups
were compared by using the t-test. Cardiovascular re-
sponse parameters were described by a linear mixed
regression model for repeated measurements. Based on
this model group differences between the exposure and
control group were tested. For expression analysis of
various parameters from lung and heart tissues, a two-
way analysis of variance (ANOVA) was used to analyze
differences between the groups. However, for the plasma
rennin and angiotensin (I and II) data the normality as-
sumption did not hold. Therefore, the Wilcoxon rank
sum test was performed for plasma rennin and angioten-
sin (I and II) concentration. P values less than 0.05 were
considered as statistically significant. All computations
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5.0 (Manugistics, Rockville, MD) and SAS V9.1 (Cary,
NC). Data are presented as arithmetic mean values of n
observations ± the standard error (SE), unless otherwise
indicated.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SU, KG, TS, and HS conceived and designed the experiments; SU, KG, MCS
and UPK performed experiments; SU, KG, LG, UPK and HS performed data
analysis; SU, TS, KG, LG, UPK, and HS wrote the manuscript. All authors read
and approved the final manuscript.
Acknowledgement
[SU] Council for Scientific and Industrial Research (CSIR); Government of India
[Reference: CSIR-SRA (13-8553A)-2012/POOL].
Disclaimer
The research described in this article has been reviewed by the National
Health and Environmental Effects Research Laboratory, U.S. Environmental
Protection Agency, and approved for publication. Approval does not signify
that the contents necessarily reflect the views and policies of the Agency,
nor does the mention of trade names of commercial products constitute
endorsement or recommendation for use.
Author details
1Institute of Lung Biology and Disease, Comprehensive Pneumology Center
Helmholtz Zentrum München, German Research Center for Environmental
Health, Munich, Germany. 2Department of Biotechnology, Indian Institute of
Technology, Madras, Chennai 600036, India. 3SRM Research Institute, SRM
University, Chennai 603203, India. 4Environmental Public Health Division,
National Health and Environmental Effects Research Laboratory, U.S.
Environmental Protection Agency, Research Triangle Park, North Carolina, NC
27711, USA. 5Institute of Epidemiology I, Helmholtz Zentrum München,
German Research Center for Environmental Health, D-85764 Neuherberg/
München, Germany.
Received: 13 March 2014 Accepted: 29 July 2014
References
1. Hoek G, Krishnan RM, Beelen R, Peters A, Ostro B, Brunekreef B, Kaufman JD:
Long-term air pollution exposure and cardio- respiratory mortality:
a review. Environ Health 2013, 12:43.
2. Prüss-Üstün A, Corvalán C: Preventing disease through healthy
environments. Towards an estimate of the environmental burden of disease.
Geneva: WHO; 2006.
3. Rich DQ, Kipen HM, Huang W, Wang G, Wang Y, Zhu P, Ohman-Strickland P,
Hu M, Philipp C, Diehl SR, Lu SE, Tong J, Gong J, Thomas D, Zhu T, Zhang JJ:
Association between changes in air pollution levels during the Beijing
Olympics and biomarkers of inflammation and thrombosis in healthy
young adults. JAMA 2012, 307:2068–2078.
4. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R,
Mittleman M, Samet J, Smith SC Jr, Tager I: Air pollution and
cardiovascular disease: a statement for healthcare professionals from the
Expert Panel on Population and Prevention Science of the American
Heart Association. Circulation 2004, 109:2655–2671.
5. Nichols JL, Owens EO, Dutton SJ, Luben TJ: Systematic review of the
effects of black carbon on cardiovascular disease among individuals
with pre-existing disease. Int J Public Health 2013, 58:707–724.
6. Sacks JD, Stanek LW, Luben TJ, Johns DO, Buckley BJ, Brown JS, Ross M:
Particulate matter-induced health effects: who is susceptible? Environ
Health Perspect 2011, 119:446–454.
7. AQMP: Air quality management plan revised draft. ; 2012.
8. Healthy eating index-2010 reports. [http://www.cnpp.usda.gov/
HealthyEatingIndex.htm]
9. Barraza-Villarreal A, Escamilla-Nunez MC, Hernandez-Cadena L, Texcalac-
Sangrador JL, Sienra-Monge JJ, Del Rio-Navarro BE, Cortez-Lugo M, Sly PD,Romieu I: Elemental carbon exposure and lung function in school children
from Mexico City. Eur Respir J 2011, 38:548–552.
10. Barraza-Villarreal A, Sunyer J, Hernandez-Cadena L, Escamilla-Nunez MC,
Sienra-Monge JJ, Ramirez-Aguilar M, Cortez-Lugo M, Holguin F, Diaz-
Sanchez D, Olin AC, Romieu I: Air pollution, airway inflammation, and lung
function in a cohort study of Mexico City schoolchildren. Environ Health
Perspect 2008, 116:832–838.
11. Nemmar A, Holme JA, Rosas I, Schwarze PE, Alfaro-Moreno E: Recent
advances in particulate matter and nanoparticle toxicology: a review of
the in vivo and in vitro studies. Biomed Res Int 2013, 2013:279371.
12. Khandoga A, Stoeger T, Khandoga AG, Bihari P, Karg E, Ettehadieh D,
Lakatos S, Fent J, Schulz H, Krombach F: Platelet adhesion and fibrinogen
deposition in murine microvessels upon inhalation of nanosized carbon
particles. J Thromb Haemost 2010, 8:1632–1640.
13. Schwarze PE, Totlandsdal AI, Lag M, Refsnes M, Holme JA, Ovrevik J:
Inflammation-related effects of diesel engine exhaust particles: studies
on lung cells in vitro. Biomed Res Int 2013, 2013:685142.
14. Chalupa DC, Morrow PE, Oberdorster G, Utell MJ, Frampton MW: Ultrafine
particle deposition in subjects with asthma. Environ Health Perspect 2004,
112:879–882.
15. Daigle CC, Chalupa DC, Gibb FR, Morrow PE, Oberdorster G, Utell MJ,
Frampton MW: Ultrafine particle deposition in humans during rest and
exercise. Inhal Toxicol 2003, 15:539–552.
16. Wallenborn JG, McGee JK, Schladweiler MC, Ledbetter AD, Kodavanti UP:
Systemic translocation of particulate matter-associated metals following
a single intratracheal instillation in rats. Toxicol Sci 2007, 98:231–239.
17. Kreyling WG, Hirn S, Moller W, Schleh C, Wenk A, Celik G, Lipka J, Schaffler
M, Haberl N, Johnston BD, Sperling R, Schmid G, Simon U, Parak WJ,
Semmler-Behnke M: Air-blood barrier translocation of tracheally instilled
gold nanoparticles inversely depends on particle size. ACS Nano 2014,
28:222–233.
18. Kreyling WG, Hirn S, Schleh C: Nanoparticles in the lung. Nat Biotechnol
2010, 28:1275–1276.
19. Stoeger T, Schmid O, Takenaka S, Schulz H: Inflammatory response to TiO2
and carbonaceous particles scales best with BET surface area. Environ
Health Perspect 2007, 115:A290–A291. author reply A291-292.
20. Sager TM, Kommineni C, Castranova V: Pulmonary response to
intratracheal instillation of ultrafine versus fine titanium dioxide: role of
particle surface area. Part Fibre Toxicol 2008, 5:17.
21. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H,
Semmler M, Im Hof V, Heyder J, Gehr P: Ultrafine particles cross cellular
membranes by nonphagocytic mechanisms in lungs and in cultured
cells. Environ Health Perspect 2005, 113:1555–1560.
22. Frampton MW, Stewart JC, Oberdorster G, Morrow PE, Chalupa D,
Pietropaoli AP, Frasier LM, Speers DM, Cox C, Huang LS, Utell MJ: Inhalation
of ultrafine particles alters blood leukocyte expression of adhesion
molecules in humans. Environ Health Perspect 2006, 114:51–58.
23. BéruBé K, Balharry D, Sexton K, Koshy L, Jones T: Combustionderived
nanoparticles: mechanisms of pulmonary toxicity. Clin Exp Pharmacol
Physiol 2007, 34(10):1044–1050.
24. Stoeger T, Takenaka S, Frankenberger B, Ritter B, Karg E, Maier K, Schulz H,
Schmid O: Deducing in vivo toxicity of combustionderived nanoparticles
from a cell-free oxidative potency assay and metabolic activation of
organic compounds. Environ Health Perspect 2009, 117:54–60.
25. Su DS, Jentoft RE, Muller JO, Rothe D, Jacob E, Simpson CD, Tomovic Z,
Mullen K, Messerer A, Poschl U, Niessner R, Schlogl R: Microstructure and
oxidation behaviour of Euro IV diesel engine soot: a comparative study
with synthetic model soot substances. Catal Today 2004, 90(1):127–132.
26. Bourdon JA, Halappanavar S, Saber AT, Jacobsen NR, Williams A, Wallin H,
Vogel U, Yauk CL: Hepatic and pulmonary toxicogenomic profiles in mice
intratracheally instilled with carbon black nanoparticlesreveal pulmonary
inflammation, acute phase response, and alterations in lipid
homeostasis. Toxicol Sci 2012, 127(2):474–484.
27. Jacobsen NR, Moller P, Jensen KA, Vogel U, Ladefoged O, Loft S, Wallin H:
Lung inflammation and genotoxicity following pulmonary exposure to
nanoparticles in ApoE−/− mice. Part Fibre Toxicol 2009, 6:2.
28. Karg E, Roth C, Heyder J: Do inhaled ultrafine particles cause acute health
effects in rats? II: Exposure system. J Aerosol Sci 1998, 29(1):S315–S316.
29. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV,
Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D,
Smith SC Jr, Whitsel L, Kaufman JD: Particulate matter air pollution and
Upadhyay et al. Particle and Fibre Toxicology 2014, 11:36 Page 17 of 18
http://www.particleandfibretoxicology.com/content/11/1/36cardiovascular disease: an update to the scientific statement from the
American Heart Association. Circulation 2010, 121:2331–2378.
30. Gold DR, Mittleman MA: New insights into pollution and the
cardiovascular system: 2010 to 2012. Circulation 2013, 127:1903–1913.
31. Upadhyay S, Stoeger T, Harder V, Thomas RF, Schladweiler MC, Semmler-
Behnke M, Takenaka S, Karg E, Reitmeir P, Bader M, Stampfl A, Kodavanti UP,
Schulz H: Exposure to ultrafine carbon particles at levels below detectable
pulmonary inflammation affects cardiovascular performance in
spontaneously hypertensive rats. Part Fibre Toxicol 2008, 5:19.
32. Hermann K, Ganten D, Unger T, Bayer C, Lang RE: Measurement and
characterization of angiotensin peptides in plasma. Clin Chem 1988,
34:1046–1051.
33. Miller MR, Shaw CA, Langrish JP: From particles to patients: oxidative
stress and the cardiovascular effects of air pollution. Future Cardiol 2012,
8:577–602.
34. Sager TM, Wolfarth MW, Battelli LA, Leonard SS, Andrew M, Steinbach T,
Endo M, Tsuruoka S, Porter DW, Castranova V: Investigation of the
pulmonary bioactivity of double-walled carbon nanotubes. J Toxicol
Environ Health A 2013, 76:922–936.
35. Stewart JC, Chalupa DC, Devlin RB, Frasier LM, Huang LS, Little EL, Lee SM,
Phipps RP, Pietropaoli AP, Taubman MB, Utell MJ, Frampton MW: Vascular
effects of ultrafine particles in persons with type 2 diabetes. Environ
Health Perspect 2010, 118:1692–1698.
36. Chang CC, Hwang JS, Chan CC, Cheng TJ: Interaction effects of
ultrafine carbon black with iron and nickel on heart rate variability in
spontaneously hypertensive rats. Environ Health Perspect 2007,
115:1012–1017.
37. Pinto YM, Paul M, Ganten D: Lessons from rat models of hypertension:
from Goldblatt to genetic engineering. Cardiovasc Res 1998, 39:77–88.
38. Doggrell SA, Brown L: Rat models of hypertension, cardiac hypertrophy
and failure. Cardiovasc Res 1998, 39:89–105.
39. Pope CA 3rd, Muhlestein JB, May HT, Renlund DG, Anderson JL, Horne BD:
Ischemic heart disease events triggered by short-term exposure to fine
particulate air pollution. Circulation 2006, 114:2443–2448.
40. Peel JL, Metzger KB, Klein M, Flanders WD, Mulholland JA, Tolbert PE:
Ambient air pollution and cardiovascular emergency department
visits in potentially sensitive groups. Am J Epidemiol 2007, 165:625–633.
41. Ruckerl R, Schneider A, Breitner S, Cyrys J, Peters A: Health effects of
particulate air pollution: a review of epidemiological evidence. Inhal
Toxicol 2011, 23:555–592.
42. Upadhyay S, Ganguly K, Stoeger T, Semmler-Bhenke M, Takenaka S, Kreyling
WG, Pitz M, Reitmeir P, Peters A, Eickelberg O, Wichmann HE, Schulz H:
Cardiovascular and inflammatory effects of intratracheally instilled
ambient dust from Augsburg, Germany, in spontaneously hypertensive
rats (SHRs). Part Fibre Toxicol 2010, 7:27.
43. Sun Q, Yue P, Ying Z, Cardounel AJ, Brook RD, Devlin R, Hwang JS, Zweier
JL, Chen LC, Rajagopalan S: Air pollution exposure potentiates
hypertension through reactive oxygen species-mediated activation of
Rho/ROCK. Arterioscler Thromb Vasc Biol 2008, 28:1760–1766.
44. Terzano C, Di Stefano F, Conti V, Graziani E, Petroianni A: Air pollution
ultrafine particles: toxicity beyond the lung. Eur Rev Med Pharmacol Sci
2010, 14:809–821.
45. Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P,
Takenaka S, Oberdorster G: Size dependence of the translocation of
inhaled iridium and carbon nanoparticle aggregates from the lung of
rats to the blood and secondary target organs. Inhal Toxicol 2009,
21(Suppl 1):55–60.
46. Kodavanti UP, Schladweiler MC, Gilmour PS, Wallenborn JG, Mandavilli BS,
Ledbetter AD, Christiani DC, Runge MS, Karoly ED, Costa DL, Peddada S,
Jaskot R, Richards JH, Thomas R, Madamanchi NR, Nyska A: The role of
particulate matter-associated zinc in cardiac injury in rats. Environ Health
Perspect 2008, 116:13–20.
47. Gilmour PS, Nyska A, Schladweiler MC, McGee JK, Wallenborn JG, Richards
JH, Kodavanti UP: Cardiovascular and blood coagulative effects of
pulmonary zinc exposure. Toxicol Appl Pharmacol 2006, 211:41–52.
48. Mutlu GM, Green D, Bellmeyer A, Baker CM, Burgess Z, Rajamannan N,
Christman JW, Foiles N, Kamp DW, Ghio AJ, Chandel NS, Dean DA, Sznajder
JI, Budinger GR: Ambient particulate matter accelerates coagulation via
an IL-6-dependent pathway. J Clin Invest 2007, 117:2952–2961.
49. Budinger GR, McKell JL, Urich D, Foiles N, Weiss I, Chiarella SE, Gonzalez A,
Soberanes S, Ghio AJ, Nigdelioglu R, Mutlu EA, Radigan KA, Green D,Kwaan HC, Mutlu GM: Particulate matter-induced lung inflammation
increases systemic levels of PAI-1 and activates coagulation through
distinct mechanisms. PLoS One 2011, 6:e18525.
50. Steffel J, Luscher TF, Tanner FC: Tissue factor in cardiovascular diseases:
molecular mechanisms and clinical implications. Circulation 2006,
113:722–731.
51. Devlin RB, Ghio AJ, Kehrl H, Sanders G, Cascio W: Elderly humans exposed
to concentrated air pollution particles have decreased heart rate
variability. Eur Respir J Suppl 2003, 40:76s–80s.
52. Power KL, Balmes J, Solomon C: Controlled exposure to combined
particles and ozone decreases heart rate variability. J Occup Environ Med
2008, 50(11):1253–1260.
53. Fan ZT, Meng Q, Weisel C, Laumbach R, Ohman-Strickland P, Shalat S,
Hernandez MZ, Black K: Acute exposure to elevated PM2.5 generated by
traffic and cardiopulmonary health effects in healthy olderadults. J Expo
Sci Environ Epidemiol 2009, 19(5):525–533.
54. Timonen KL, Vanninen E, de Hartog J, Ibald-Mulli A, Brunekreef B, Gold DR,
Heinrich J, Hoek G, Lanki T, Peters A, Tarkiainen T, Tiittanen P, Kreyling W,
Pekkanen J: Effects of ultrafine and fine particulate and gaseous air
pollution on cardiac autonomic control in subjects with coronary artery
disease: the ULTRA study. J Expo Sci Environ Epidemiol 2006, 16(4):332–341.
55. Gauldie J, Northemann W, Fey GH: IL-6 functions as an exocrine hormone
in inflammation. Hepatocytes undergoing acute phase responses require
exogenous IL-6. J Immunol 1990, 144:3804–3808.
56. Riediker M, Cascio WE, Griggs TR, Herbst MC, Bromberg PA, Neas L, Williams
RW, Devlin RB: Particulate matter exposure in cars is associated with
cardiovascular effects in healthy young men. Am J Respir Crit Care Med
2004, 169:934–940.
57. Ruckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, Heinrich
J, Marder V, Frampton M, Wichmann HE, Peters A: Air pollution and
markers of inflammation and coagulation in patients with coronary heart
disease. Am J Respir Crit Care Med 2006, 173:432–441.
58. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other
markers of inflammation inthe prediction of cardiovascular disease in
women. N Engl J Med 2000, 342(12):836–843.
59. Saber AT, Lamson JS, Jacobsen NR, Ravn-Haren G, Hougaard KS, Nyendi AN,
Wahlberg P, Madsen AM, Jackson P, Wallin H, Vogel U: Particle-induced
pulmonary acute phase response correlates with neutrophil influx linking
inhaled particles and cardiovascular risk. PLoS One 2013, 8:e69020.
60. Higashisaka K, Yoshioka Y, Yamashita K, Morishita Y, Fujimura M, Nabeshi H,
Nagano K, Abe Y, Kamada H, Tsunoda S, Yoshikawa T, Itoh N, Tsutsumi Y:
Acute phase proteins as biomarkers for predicting the exposure and
toxicity of nanomaterials. Biomaterials 2011, 32:3–9.
61. Rohr AC, Wagner JG, Morishita M, Kamal A, Keeler GJ, Harkema JR:
Cardiopulmonary responses in spontaneously hypertensive and Wistar-
Kyoto rats exposed to concentrated ambient particles from Detroit,
Michigan. Inhal Toxicol 2010, 22:522–533.
62. Farina F, Sancini G, Battaglia C, Tinaglia V, Mantecca P, Camatini M, Palestini P:
Milano summer particulate matter (PM10) triggers lung inflammation and
extra pulmonary adverse events in mice. PLoS One 2013, 8:e56636.
63. Halcox JP, Nour KR, Zalos G, Quyyumi AA: Endogenous endothelin in
human coronary vascular function: differential contribution of
endothelin receptor types A and B. Hypertension 2007, 49:1134–1141.
64. Chauhan V, Breznan D, Thomson E, Karthikeyan S, Vincent R: Effects of
ambient air particles on the endothelin system in human pulmonary
epithelial cells (A549). Cell Biol Toxicol 2005, 21:191–205.
65. Karthikeyan S, Thomson EM, Kumarathasan P, Guenette J, Rosenblatt D,
Chan T, Rideout G, Vincent R: Nitrogen dioxide and ultrafine particles
dominate the biological effects of inhaled diesel exhaust treated by a
catalyzed diesel particulate filter. Toxicol Sci 2013, 135:437–450.
66. Kobayshi T, Miyauchi T, Sakai S, Maeda S, Yamaguchi I, Goto K, Sugishita Y:
Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive
lung secondary to heart failure. Are marked increases in circulating
endothelin-1 partly attributable to decreases in lung ET(B) receptor-
mediated clearance of endothelin-1? Life Sci 1998, 62:185–193.
67. Khimji AK, Rockey DC: Endothelin–biology and disease. Cell Signal 2010,
22:1615–1625.
68. Bourden JA, Saber AT, Jacobsen NR, Williams A, Vogel U, Wallin H,
Hallppanavar S, Yauk CL: Carbon black nanoparticle Intratracheal
instillation does not alter cardiac gene expression. Cardiovasc Toxicol
2013, 13:406–412.
Upadhyay et al. Particle and Fibre Toxicology 2014, 11:36 Page 18 of 18
http://www.particleandfibretoxicology.com/content/11/1/3669. Schulz H, Muhle H: The laboratory Rat. In The handbook of experimental
animals. Edited by Krinke GJ. San Diego: Academic; 2000.
70. Singh U, Jialal I: Oxidative stress and atherosclerosis. Pathophysiology 2006,
13:129–142.
71. Victor VM, Rocha M, Sola E, Banuls C, Garcia-Malpartida K, Hernandez-Mijares A:
Oxidative stress, endothelial dysfunction and atherosclerosis.
Curr Pharm Des 2009, 15:2988–3002.
72. Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, Young SH, Shvedova
A, Luster MI, Simeonova PP: Cardiovascular effects of pulmonary exposure
to single-wall carbon nanotubes. Environ Health Perspect 2007,
115:377–382.
73. Choi AM, Alam J: Heme oxygenase-1: function, regulation, and implication
of a novel stress-inducible protein in oxidant-induced lung injury.
Am J Respir Cell Mol Biol 1996, 15:9–19.
74. Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J,
Schulz H: Instillation of six different ultrafine carbon particles indicates a
surface area threshold dose for acute lung inflammation in mice. Environ
Health Perspect 2006, 114(3):328–333.
75. Brown JS, Wilson WE, Grant LD: Dosimetric comparisons of particle
deposition and retention in rats and humans. Inhal Toxicol 2005,
17(7–8):355–385.
76. Sioutas C, Delfino RJ, Singh M: Exposure assessment for atmospheric
ultrafine particles (UFPs) and implications in epidemiologic research.
Environ Health Perspect 2005, 113(8):947–955.
77. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG:
Long-term clearance kinetics of inhaled ultrafine insoluble iridium
particles from the rat lung, including transient translocation into
secondary organs. Inhal Toxicol 2004, 16(6–7):453–459.
78. Geiser M, Kreyling WG: Deposition and biokinetics of inhaled
nanoparticles. Part Fibre Toxicol 2010, 7:2.
79. Rich DQ, Ozkaynak H, Crooks J, Baxter L, Burke J, Ohman-Strickland P,
Thevenet-Morrison K, Kipen HM, Zhang J, Kostis JB, Lunden M, Hodas N,
Turpin BJ: The triggering of myocardial infarction by fine particles is
enhanced when particles are enriched in secondary species. Environ Sci
Technol 2013, 47:9414–9423.
80. Barnett AG, Williams GM, Schwartz J, Best TL, Neller AH, Petroeschevsky AL,
Simpson RW: The effects of air pollution on hospitalizations for
cardiovascular disease in elderly people in Australian and New Zealand
cities. Environ Health Perspect 2006, 114:1018–1023.
81. Harder V, Gilmour P, Lentner B, Karg E, Takenaka S, Ziesenis A, Stampfl A,
Kodavanti U, Heyder J, Schulz H: Cardiovascular responses in unrestrained
WKY rats to inhaled ultrafine carbon particles. Inhal Toxicol 2005,
17:29–42.
82. Kodavanti UP, Moyer CF, Ledbetter AD, Schladweiler MC, Costa DL, Hauser
R, Christiani DC, Nyska A: Inhaled environmental combustion particles
cause myocardial injury in the Wistar Kyoto rat. Toxicol Sci 2003,
71:237–245.
83. Kodavanti UP, Schladweiler MC, Ledbetter AD, Watkinson WP, Campen MJ,
Winsett DW, Richards JR, Crissman KM, Hatch GE, Costa DL: The
spontaneously hypertensive rat as a model of human cardiovascular
disease: evidence of exacerbated cardiopulmonary injury and oxidative
stress from inhaled emission particulate matter. Toxicol Appl Pharmacol
2000, 164:250–263.
84. Karoly ED, Li Z, Dailey LA, Hyseni X, Huang YC: Up-regulation of tissue
factor in human pulmonary artery endothelial cells after ultrafine
particle exposure. Environ Health Perspect 2007, 115:535–540.
85. Franchini M, Guida A, Tufano A, Coppola A: Air pollution, vascular disease
and thrombosis: linking clinical data and pathogenic mechanisms.
J Thromb Haemost 2012, 10(12):2438–2451. doi:10.1111/jth.12006.
86. Kodavanti UP, Schladweiler MC, Ledbetter AD, Hauser R, Christiani DC,
McGee J, Richards JR, Costa DL: Temporal association between pulmonary
and systemic effects of particulate matter in healthy and cardiovascular
compromised rats. J Toxicol Environ Health A 2002, 65:1545–1569.
doi:10.1186/s12989-014-0036-6
Cite this article as: Upadhyay et al.: Ultrafine carbon particle mediated
cardiovascular impairment of aged spontaneously hypertensive rats.
Particle and Fibre Toxicology 2014 11:36.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
